118 related articles for article (PubMed ID: 23722300)
1. S100P predicts prognosis and drug resistance in gastric cancer.
Ge F; Wang C; Wang W; Wu B
Int J Biol Markers; 2013 Dec; 28(4):e387-92. PubMed ID: 23722300
[TBL] [Abstract][Full Text] [Related]
2. S100P enhances the chemosensitivity of human gastric cancer cell lines.
Zhao X; Bai Z; Wu P; Zhang Z
Cancer Biomark; 2013; 13(1):1-10. PubMed ID: 23736016
[TBL] [Abstract][Full Text] [Related]
3. [Discovery and verification of matrix gla protein, a TNM staging and prognosis-related biomarker for gastric cancer].
Guo L; Guo XB; Jiang JL; Zhang JN; Ji J; Liu BY; Zhu ZG; Yu YY
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):436-41. PubMed ID: 21055170
[TBL] [Abstract][Full Text] [Related]
4. [Impact of S100P expression on clinical outcomes of gastric cancer patients with adjuvant chemotherapy of oxaliplatin and its mechanisms].
Zhao XM; Bai ZG; Ma XM; Zhang ZT; Shi XY
Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):1004-8. PubMed ID: 21054985
[TBL] [Abstract][Full Text] [Related]
5. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
[TBL] [Abstract][Full Text] [Related]
6. Expression and significance of S100P, CD147, and OCT4 in different prostate cancer tissue TNM stages.
Wang Q; Zhang JG; Wang W
Genet Mol Res; 2015 Jun; 14(2):6844-51. PubMed ID: 26125892
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of S100P by lentiviral-mediated RNAi promotes apoptosis and suppresses the colony-formation ability of gastric cancer cells.
Zhang Q; Hu H; Shi X; Tang W
Oncol Rep; 2014 May; 31(5):2344-50. PubMed ID: 24677114
[TBL] [Abstract][Full Text] [Related]
8. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.
Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y
Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
[TBL] [Abstract][Full Text] [Related]
10. S100P, a potential novel prognostic marker in colorectal cancer.
Wang Q; Zhang YN; Lin GL; Qiu HZ; Wu B; Wu HY; Zhao Y; Chen YJ; Lu CM
Oncol Rep; 2012 Jul; 28(1):303-10. PubMed ID: 22552710
[TBL] [Abstract][Full Text] [Related]
11. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
[TBL] [Abstract][Full Text] [Related]
12. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
13. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.
Whiteman HJ; Weeks ME; Dowen SE; Barry S; Timms JF; Lemoine NR; Crnogorac-Jurcevic T
Cancer Res; 2007 Sep; 67(18):8633-42. PubMed ID: 17875703
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
Jang BG; Lee BL; Kim WH
Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
[TBL] [Abstract][Full Text] [Related]
16. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer.
Ichikawa W; Terashima M; Ochiai A; Kitada K; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):263-273. PubMed ID: 26884344
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of S100P expression by non-steroidal anti-inflammatory drugs and its role in anti-tumorigenic effects.
Namba T; Homan T; Nishimura T; Mima S; Hoshino T; Mizushima T
J Biol Chem; 2009 Feb; 284(7):4158-67. PubMed ID: 19073601
[TBL] [Abstract][Full Text] [Related]
18. S100P is a molecular determinant of E-cadherin function in gastric cancer.
Carneiro P; Moreira AM; Figueiredo J; Barros R; Oliveira P; Fernandes MS; Ferro A; Almeida R; Oliveira C; Carneiro F; Schmitt F; Paredes J; Velho S; Seruca R
Cell Commun Signal; 2019 Nov; 17(1):155. PubMed ID: 31767037
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer.
Hammacher A; Thompson EW; Williams ED
Int J Biochem Cell Biol; 2005 Feb; 37(2):442-50. PubMed ID: 15474988
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer.
Cheng WL; Wang CS; Huang YH; Liang Y; Lin PY; Hsueh C; Wu YC; Chen WJ; Yu CJ; Lin SR; Lin KH
Int J Cancer; 2008 Oct; 123(8):1787-96. PubMed ID: 18688858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
